← All compounds

BPC-157

10mg vial
A$ 142Rp 1.600.000
Bulk buy pricing
3–5 vials
A$ 129
Save ~9%
6–9 vials
A$ 125
Save ~13%
10+ vials
A$ 111
Save ~22%

A body-protective compound studied for faster healing of soft tissue, tendons, ligaments, and the lining of the gut. Research shows regenerative action on blood vessels and connective tissue, supporting recovery from injury and gastrointestinal inflammation.

Compound overview

What it is

BPC-157 (Body Protective Compound-157) is a pentadecapeptide derived from a protein found in human gastric juice. It promotes angiogenesis (new blood vessel formation), upregulates growth factor receptors including VEGFR and EGFR, and modulates nitric oxide synthesis. It stabilises tendon, ligament, and connective tissue healing through fibroblast proliferation and enhances gut mucosal repair via interaction with the enteric nervous system.

Healing of soft tissue injuries accelerates — tears, sprains, and tendon injuries respond within weeks in animal studies and clinical anecdotes. The gut lining repairs under inflammatory conditions. Nitric oxide-mediated blood vessel formation improves local blood supply to damaged tissue. Pain associated with inflammatory injury often reduces early in the protocol.

Studied outcomes
  • Accelerated tendon and ligament healing in preclinical models
  • Gut mucosal healing in colitis and IBD models
  • Angiogenic activity supporting blood supply to healing tissue
  • Reduction of inflammatory markers at injury sites
  • Protective action on the intestinal epithelium against NSAID damage
Suitability

Who it's for

  • Recovery from tendon, ligament, or soft tissue injuries
  • Post-surgical tissue healing support
  • Gut permeability and gastrointestinal inflammation — leaky gut, IBD adjunct
  • Chronic injuries that have failed to progress through standard rehabilitation
Who should avoid it
  • Active cancer — angiogenic activity is a theoretical concern (limited direct evidence)
  • Pregnancy (insufficient safety data)
  • Those with a history of hormone-sensitive tumours
Dosing guidance

Protocol guidance

Dose
250–500mcg per day
Frequency
Once or twice daily
Cycle length
4–12 weeks depending on injury severity; gut protocols often run 4–6 weeks
Route
Subcutaneous injection near the injury site (for local healing) or in the abdomen (systemic). Oral route studied for gut conditions.
Timing
No strict timing requirement; morning or split AM/PM dosing works well
Safety

Contraindications & cautions

  • Theoretical angiogenic risk in those with active or recent cancer — avoid without oncology clearance
  • Well-tolerated in studies; side-effect profile appears low
  • Limited large-scale human trial data — widely used in research and clinical settings
  • Combine with proper rehabilitation for best structural outcomes
Stacking

Pairs well with

The classic injury recovery stack — BPC-157 for local connective tissue repair, TB-500 for systemic cellular migration and healing

Anti-inflammatory support at the cellular level enhances BPC-157 gut and tissue repair

GHK-Cu adds skin and collagen regeneration on top of connective tissue healing

Evidence base

Research

Sikiric et al. (2018) — BPC-157 review: tendon, gut, and angiogenesis ↗Chang et al. (2011) — BPC-157 and gut protection ↗

Not medical advice. Not a substitute for medical care. Consult your licensed practitioner before beginning any protocol. Peptides are sold for research purposes only and are suitable for adults aged 18 years and over.